American Century Companies Inc Spring Works Therapeutics, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
SELL
$36.06 - $47.62 $73,273 - $96,763
-2,032 Reduced 20.81%
7,733 $291,000
Q1 2024

May 14, 2024
BUY
$36.5 - $52.5 $111,653 - $160,597
3,059 Added 45.62%
9,765 $480,000
Q4 2023

Feb 13, 2024
BUY
$18.94 - $37.24 $127,011 - $249,731
6,706 New
6,706 $244,000
Q1 2023

May 11, 2023
BUY
$24.97 - $34.05 $267,403 - $364,641
10,709 New
10,709 $275,000

Others Institutions Holding SWTX

# of Institutions
237
Shares Held
68.9M
Call Options Held
144K
Put Options Held
257K
View Full List

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.25B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email